Difference between revisions of "Spindle cell lesions"

From Libre Pathology
Jump to navigation Jump to search
(more)
m (→‎IHC: more)
Line 18: Line 18:
*AE1/AE3 (pankeratin).
*AE1/AE3 (pankeratin).


===Big panel===
===Big panels===
A MSH panel:
====A MSH MFH panel====
*CD34 - [[GIST]], [[angiosarcoma]], [[solitary fibrous tumour]]/[[hemangiopericytoma]], [[Kaposi sarcoma]], [[DFSP]].
*CD34 - [[GIST]], [[angiosarcoma]], [[solitary fibrous tumour]]/[[hemangiopericytoma]], [[Kaposi sarcoma]], [[DFSP]].
*S100 - neural marker, sensitive for [[malignant melanoma]], Langerhans cells, [[clear cell sarcoma]].
*S100 - neural marker, sensitive for [[malignant melanoma]], Langerhans cells, [[clear cell sarcoma]].
Line 36: Line 36:
*Beta-catenin - a small subset of soft tissue lesions:
*Beta-catenin - a small subset of soft tissue lesions:
**Desmoidtype [[fibromatosis]] (~70%), solitary fibrous tumour & endometrial stromal sarcoma (~40%), synovial sarcoma (~30%).<ref name=pmid15375433>{{cite journal |author=Ng TL, Gown AM, Barry TS, ''et al.'' |title=Nuclear beta-catenin in mesenchymal tumors |journal=Mod. Pathol. |volume=18 |issue=1 |pages=68–74 |year=2005 |month=January |pmid=15375433 |doi=10.1038/modpathol.3800272 |url=}}</ref>
**Desmoidtype [[fibromatosis]] (~70%), solitary fibrous tumour & endometrial stromal sarcoma (~40%), synovial sarcoma (~30%).<ref name=pmid15375433>{{cite journal |author=Ng TL, Gown AM, Barry TS, ''et al.'' |title=Nuclear beta-catenin in mesenchymal tumors |journal=Mod. Pathol. |volume=18 |issue=1 |pages=68–74 |year=2005 |month=January |pmid=15375433 |doi=10.1038/modpathol.3800272 |url=}}</ref>
====A MFH DJH panel====
*Vimentin.
*Alpha-1-antichymotrypsin.
*CD34.
*SMA.
*S-100.
*Keratin 5D3.
*Keratin LP34.
*EMA.
*MSA.
*Caldesmon.
*MYF-4.
*HMB45.
*Mart-1.
*Tyrosinase.


==See also==
==See also==

Revision as of 14:40, 12 April 2011

Spindle cell lesions are seen frequent enough that one ought to have a solid approach to 'em.

General DDx

Spindle cells should make think:

  • Nerve.
  • Muscle.
    • Smooth.
    • Skeletal.
  • Other.

IHC

Basic panel

Dixon panel:[1]

  • CD34.
  • Desmin.
  • SMA.
  • S100.
  • AE1/AE3 (pankeratin).

Big panels

A MSH MFH panel

Others:

  • Beta-catenin - a small subset of soft tissue lesions:
    • Desmoidtype fibromatosis (~70%), solitary fibrous tumour & endometrial stromal sarcoma (~40%), synovial sarcoma (~30%).[6]

A MFH DJH panel

  • Vimentin.
  • Alpha-1-antichymotrypsin.
  • CD34.
  • SMA.
  • S-100.
  • Keratin 5D3.
  • Keratin LP34.
  • EMA.
  • MSA.
  • Caldesmon.
  • MYF-4.
  • HMB45.
  • Mart-1.
  • Tyrosinase.

See also

References

  1. BD. 1 April 2011.
  2. Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 108. ISBN 978-0470519035.
  3. Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 107. ISBN 978-0470519035.
  4. URL: http://ajp.amjpathol.org/cgi/content/full/160/3/759. Accessed on: 3 August 2010.
  5. 5.0 5.1 Ardeleanu C, Arsene D, Hinescu M, et al. (October 2009). "Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker". Appl. Immunohistochem. Mol. Morphol. 17 (5): 413–8. doi:10.1097/PAI.0b013e31819e4dc5. PMID 19417627.
  6. Ng TL, Gown AM, Barry TS, et al. (January 2005). "Nuclear beta-catenin in mesenchymal tumors". Mod. Pathol. 18 (1): 68–74. doi:10.1038/modpathol.3800272. PMID 15375433.